Evolution of a Unified Strategy for Complex Sesterterpenoids: Progress toward Astellatol and the Total Synthesis of (−)-Nitidasin
Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans‐hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the e...
Saved in:
Published in | Chemistry : a European journal Vol. 21; no. 39; pp. 13646 - 13665 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
21.09.2015
WILEY‐VCH Verlag Wiley Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans‐hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the evolution of our stereoselective strategy for isopropyl trans‐hydrindane sesterterpenoids is detailed. These endeavors included the synthesis of several building blocks, enabling studies toward all molecules of this terpenoid subclass, and of advanced intermediates of our initial route toward a biomimetic synthesis of astellatol. These findings provided the basis for a second‐generation and a third‐generation approach toward astellatol that eventually culminated in the enantioselective total synthesis of (−)‐nitidasin. In particular, a series of substrate‐controlled transformations to install the ten stereogenic centers of the target molecule was orchestrated and the carbocyclic backbone was forged in a convergent fashion. Furthermore, the progress toward the synthesis of astellatol is disclosed and insights into some observed yet unexpected diastereoselectivities by detailed quantum‐mechanical calculations are provided.
Two and a half molecules: Astellatol and nitidasin are polycyclic sesterterpenoids, posing considerable challenges for synthetic chemists. In this full account, the evolution of a synthetic strategy for these and structurally related natural products is given (see scheme). The presented work includes efforts toward a biomimetic synthesis of astellatol, a successful route for the first total synthesis of (−)‐nitidasin, and quantum‐mechanical investigations into unexpected diastereosectivities. |
---|---|
Bibliography: | National Science Foundation - No. OCI-1053575 ArticleID:CHEM201501423 Fonds der Chemischen Industrie istex:81E26CCF613D9AF723127958587933664200B791 ark:/67375/WNG-K58P1XFN-9 Deutsche Forschungsgemeinschaft - No. SFB 749 NIH-NIGMS - No. GM075962 UCLA Institute of Digital Research and Education (IDRE) ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Dedicated to Prof. Wolfgang Steglich Present address: Bayer Health Care, Bayer Pharma AG BPH-GDD-CGEI-MCB-MCII, Müllerstr. 178, 13353 Berlin, Germany. |
ISSN: | 0947-6539 1521-3765 |
DOI: | 10.1002/chem.201501423 |